sk&f-38393 has been researched along with Basal Ganglia Diseases in 2 studies
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, A | 1 |
| Mouradian, MM | 1 |
| Mohr, E | 1 |
| Fabbrini, G | 1 |
| Chase, TN | 1 |
| Gerlach, J | 1 |
| Casey, D | 1 |
| Kistrup, K | 1 |
1 trial available for sk&f-38393 and Basal Ganglia Diseases
| Article | Year |
|---|---|
Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aged; Basal Ganglia Diseases; Ben | 1989 |
1 other study available for sk&f-38393 and Basal Ganglia Diseases
| Article | Year |
|---|---|
D-1 and D-2 receptor manipulation in Cebus monkeys: implication for extrapyramidal syndromes in humans.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Basal Ganglia Diseases; Benzaze | 1986 |